40 related articles for article (PubMed ID: 38569701)
1. Multiple myeloma: patient outcomes in real-world practice.
Yong K; Delforge M; Driessen C; Fink L; Flinois A; Gonzalez-McQuire S; Safaei R; Karlin L; Mateos MV; Raab MS; Schoen P; Cavo M
Br J Haematol; 2016 Oct; 175(2):252-264. PubMed ID: 27411022
[TBL] [Abstract][Full Text] [Related]
2. Natural history of SCLC patients treated in third-line and beyond: A retrospective real world study.
Borghaei H; Pundole X; Sangaré L; Anderson E; Bebb DG; Jiang T; Pastel M; Carrigan G; Balasubramanian A; Martinez P; Ramalingam SS
Lung Cancer; 2024 May; 193():107819. PubMed ID: 38865854
[TBL] [Abstract][Full Text] [Related]
3. Biomarker guidance in selection among breakthrough treatment options in advanced and recurrent endometrial cancer.
Chan JK; Tewari K; Monk BJ; Herzog TJ; Coleman RL; Richardson MT; Kapp DS; Francoeur AA
Gynecol Oncol; 2024 Jun; 187():249-252. PubMed ID: 38838439
[No Abstract] [Full Text] [Related]
4. PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer.
Roncolato F; Lindemann K; Willson ML; Martyn J; Mileshkin L
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD012160. PubMed ID: 31588998
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration.
Humber CE; Tierney JF; Symonds RP; Collingwood M; Kirwan J; Williams C; Green JA
Ann Oncol; 2007 Mar; 18(3):409-20. PubMed ID: 17150999
[TBL] [Abstract][Full Text] [Related]
6. Real-world treatment patterns and clinical outcomes from a retrospective chart review study of patients with recurrent or advanced endometrial cancer who progressed following prior systemic therapy in Europe.
Zhang J; Kelkar SS; Prabhu VS; Qiao Y; Grall V; Miles N; Marth C
BMJ Open; 2024 Apr; 14(4):e079447. PubMed ID: 38569701
[TBL] [Abstract][Full Text] [Related]
7. Real-world prevalence of microsatellite instability testing and related status in women with advanced endometrial cancer in Europe.
Kelkar SS; Prabhu VS; Zhang J; Ogando YM; Roney K; Verma RP; Miles N; Marth C
Arch Gynecol Obstet; 2024 Jun; 309(6):2833-2841. PubMed ID: 38634898
[TBL] [Abstract][Full Text] [Related]
8. Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer who are microsatellite instability (MSI)-high or are mismatch repair deficient (dMMR) in the United States.
Kelkar SS; Prabhu VS; Corman S; Odak S; Rusibamayila N; Macahilig C; Orlowski R; Duska L
Gynecol Oncol; 2023 Feb; 169():154-163. PubMed ID: 36344294
[TBL] [Abstract][Full Text] [Related]
9. Real-world outcomes in patients with advanced endometrial cancer: A retrospective cohort study of US electronic health records.
Monk BJ; Smith G; Lima J; Long GH; Alam N; Nakamura H; Meulendijks D; Ghiorghiu D; Banerjee S
Gynecol Oncol; 2022 Feb; 164(2):325-332. PubMed ID: 34952707
[TBL] [Abstract][Full Text] [Related]
10. Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States.
Kelkar SS; Prabhu VS; Zhang J; Corman S; Macahilig C; Rusibamayila N; Odak S; Duska LR
Gynecol Oncol Rep; 2022 Aug; 42():101026. PubMed ID: 35800987
[TBL] [Abstract][Full Text] [Related]
11. Previously treated recurrent or advanced endometrial cancer in England: A real-world observational analysis.
Heffernan K; Nikitas FS; Shukla U; Camejo HS; Knott C
Gynecol Oncol; 2022 Aug; 166(2):317-325. PubMed ID: 35752507
[TBL] [Abstract][Full Text] [Related]
12. Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Oaknin A; Bosse TJ; Creutzberg CL; Giornelli G; Harter P; Joly F; Lorusso D; Marth C; Makker V; Mirza MR; Ledermann JA; Colombo N;
Ann Oncol; 2022 Sep; 33(9):860-877. PubMed ID: 35690222
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
